ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646381 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646381; 2) Community: the network communities that were significantly associated with the response to NSC 646381; 3) Molecule: the relationships between components within communities and NSC 646381; 4) MDR: the compounds that were significantly associated with the NSC 646381.

NSC Compound Enrichment Correlation
NSC 758845 Null 0.0422011701988039 0.27260579
NSC 763564 EMD-534085 0.0422011701988039 0.20477308
NSC 77039 Null 0.0422011701988039 0.34093726
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0422011701988039 0.067575783
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0422011701988039 0.4085649
NSC 87500 Solacongestidine 0.0422011701988039 0.51626259
NSC 105827 SANGIVAMYCIN,-THIO 0.0438391811600409 0.26452299
NSC 140873 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide 0.0438391811600409 0.37774778
NSC 237671 Actinomycin X4357g-methoxime 0.0438391811600409 0.31743487
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.0438391811600409 0.3060624
Total:90  Current:72    [First] [Prev] [Next] [Last]